Related Experiment Video
Updated: Nov 24, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Long Non-coding RNA X-Inactive Specific Transcript Mediates Cell Proliferation and Intrusion by Modulating the
Qinhua Liu1, Ruonan Ran2, Zhengsheng Wu3
1Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Abstract:
The present study was directed toward laying new findings for Extranodal natural killer/T-cell lymphoma (ENKL)-oriented therapy with a focus on long non-coding RNA (lncRNA)-microRNAs (miRNAs)-mRNA interaction. The expression and function of XIST (X-inactive specific transcript) were analyzed both in vivo and in vitro. The online database of lncRNA-miRNA interaction was used to screen the target of XIST, and miR-497 was selected. Next, the predicted binding between XIST and miR-497, and the dynamic effect of XIST and miR-497 on downstream Bcl-w was evaluated. We found that XIST dramatically increased in the blood of ENKL patients and cell lines. XIST knockdown suppressed the cell proliferation and migration in vivo and in vitro. Herein, we confirmed the negative interaction between XIST and miR-497. Moreover, XIST knockdown reduced the protein levels of Bcl-w, a downstream target of miR-497. XIST sponges miR-497 to promote Bcl-w expression, and finally modulating ENKL cell proliferation and migration. To be interested, inhibition of Bcl-w by ABT737 can overcome the high expression of XIST, and suppressed the ENKL proliferation and migration by inducing apoptosis. This study provided a novel experimental basis for ENKL-oriented therapy with a focus on the lncRNA-miRNA-mRNA interaction.
Insights
This study reveals that XIST long non-coding RNA promotes Extranodal natural killer/T-cell lymphoma (ENKL) growth by sponging miR-497, increasing Bcl-w. Inhibiting Bcl-w offers a therapeutic strategy for ENKL.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Extranodal natural killer/T-cell lymphoma (ENKL) is an aggressive non-Hodgkin lymphoma with limited therapeutic options.
- Dysregulation of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) plays a crucial role in tumorigenesis.
- Understanding lncRNA-miRNA-mRNA interactions is vital for developing targeted therapies.
Purpose of the Study:
- To investigate the role of XIST (X-inactive specific transcript) in ENKL pathogenesis.
- To elucidate the interaction between XIST, miR-497, and its downstream target Bcl-w in ENKL.
- To explore the therapeutic potential of targeting the XIST/miR-497/Bcl-w axis in ENKL.
Main Methods:
- Analysis of XIST expression in ENKL patients and cell lines (in vivo and in vitro).
- lncRNA-miRNA interaction database screening to identify XIST targets, selecting miR-497.
- Evaluation of XIST and miR-497 effects on downstream Bcl-w expression and ENKL cell proliferation/migration.
- Assessment of Bcl-w inhibition using ABT737 to overcome XIST effects.
Main Results:
- XIST expression was significantly upregulated in ENKL patient blood and cell lines.
- XIST knockdown inhibited ENKL cell proliferation and migration.
- A negative interaction between XIST and miR-497 was confirmed, with XIST acting as a sponge for miR-497.
- XIST knockdown reduced Bcl-w protein levels, indicating Bcl-w is a downstream target of miR-497.
- Inhibition of Bcl-w by ABT737 suppressed ENKL proliferation and migration by inducing apoptosis, overcoming XIST overexpression.
Conclusions:
- XIST promotes ENKL cell proliferation and migration by sponging miR-497 and upregulating Bcl-w.
- The XIST/miR-497/Bcl-w axis represents a novel therapeutic target for ENKL.
- Targeting Bcl-w offers a potential strategy to overcome XIST-driven ENKL progression.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Inheritance of Chromatin Structures
MicroRNAs
MicroRNAs
Abnormal Proliferation
